Result_Audited Financial Results For The Quarter And Year Ended March 31, 2026
Filed with BSE · · 18 pages · English
Earlier from Titan Biotech
- Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May, 2026
- Titan Biotech Limited Press Release May 20 2026
- Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial
- Titan Biotech Limited Press Release May 06 2026
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
Later from Titan Biotech
- Corporate Action-Board to consider Dividend
- Re-Appointment Of Cost Auditor For Financial Year 2026-2027
- Titan Biotech Limited Press Release May 30 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Jun 01 2026
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech